HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Inglessis, I. Articles by Semigran, M. J. Search for Related Content PubMed PubMed Citation Articles by Inglessis, I. Articles by Semigran, M. J.

CLINICAL RESEARCH

Hemodynamic effects of inhaled nitric oxide in right ventricular myocardial infarction and cardiogenic shock

Ignacio Inglessis, MD^*, Jordan T. Shin, MD^*,, John J. Lepore, MD^*, Igor F. Palacios, MD, FACC^*, Warren M. Zapol, MD, Kenneth D. Bloch, MD^*, and Marc J. Semigran, MD^*,*

^* Cardiology Division
Cardiovascular Research Center
Department of Anesthesia and Critical Care, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA

Manuscript received February 4, 2004; revised manuscript received April 30, 2004, accepted May 4, 2004.

^* Reprint requests and correspondence: Dr. Marc J. Semigran, Massachusetts General Hospital, Bigelow 842, 32 Fruit Street, Boston, Massachusetts 02114 (Email: msemigran{at}partners.org).

OBJECTIVES: We sought to determine whether or not inhaled nitric oxide (NO) could improve hemodynamic function in patients with right ventricular myocardial infarction (RVMI) and cardiogenic shock (CS).

BACKGROUND: Inhaled NO is a selective pulmonary vasodilator that can decrease right ventricular afterload.

METHODS: Thirteen patients (7 males and 6 females, age 65 ± 3 years) presenting with electrocardiographic, echocardiographic, and hemodynamic evidence of acute inferior myocardial infarction associated with RVMI and CS were studied. After administration of supplemental oxygen (inspired oxygen fraction [F_iO₂] = 1.0), hemodynamic measurements were recorded before, during inhalation of NO (80 ppm at F_iO₂ = 0.90) for 10 min, and 10 min after NO inhalation was discontinued (F_iO₂ = 1.0).

RESULTS: Breathing NO decreased the mean right atrial pressure by 12 ± 3%, mean pulmonary arterial pressure by 13 ± 2%, and pulmonary vascular resistance by 36 ± 8% (all p < 0.05). Nitric oxide inhalation increased the cardiac index by 24 ± 11% and the stroke volume index by 23 ± 12% (p < 0.05). The NO administration did not change systemic arterial or pulmonary capillary wedge pressures. Contrast echocardiography identified three patients with a patent foramen ovale and right-to-left shunt flow while breathing at F_iO₂ = 1.0. Breathing NO decreased shunt flow by 56 ± 5% (p < 0.05) and was associated with markedly improved systemic oxygen saturation.

CONCLUSIONS: Nitric oxide inhalation results in acutehemodynamic improvement when administered to patients with RVMI and CS.

Abbreviations and Acronyms   CI = cardiac index   CS = cardiogenic shock   FiO2 = inspired oxygen fraction   HR = heart rate   LV = left ventricle/ventricular   MI = myocardial infarction   NO = nitric oxide   PA = pulmonary artery/arterial   PCI = percutaneous coronary intervention   PCWP = pulmonary capillary wedge pressure   PVR = pulmonary vascular resistance   RA = right atrium/atrial   RV = right ventricle/ventricular   RVMI = right ventricular myocardial infarction   SAP = systemic arterial pressure   TIMI = Thrombolysis In Myocardial Infarction

This article has been cited by other articles:

				F. Haddad, R. Doyle, D. J. Murphy, and S. A. Hunt Right Ventricular Function in Cardiovascular Disease, Part II: Pathophysiology, Clinical Importance, and Management of Right Ventricular Failure Circulation, April 1, 2008; 117(13): 1717 - 1731. [Full Text] [PDF]

				M. P. Coggins and K. D. Bloch Nitric Oxide in the Pulmonary Vasculature Arterioscler. Thromb. Vasc. Biol., September 1, 2007; 27(9): 1877 - 1885. [Abstract] [Full Text] [PDF]

				K. D. Bloch, F. Ichinose, J. D. Roberts Jr., and W. M. Zapol Inhaled NO as a therapeutic agent Cardiovasc Res, July 15, 2007; 75(2): 339 - 348. [Abstract] [Full Text] [PDF]

				J. W. Elrod, J. J.M. Greer, N. S. Bryan, W. Langston, J. F. Szot, H. Gebregzlabher, S. Janssens, M. Feelisch, and D. J. Lefer Cardiomyocyte-Specific Overexpression of NO Synthase-3 Protects Against Myocardial Ischemia-Reperfusion Injury Arterioscler. Thromb. Vasc. Biol., July 1, 2006; 26(7): 1517 - 1523. [Abstract] [Full Text] [PDF]

				K. Bendjelid Does inhaled nitric oxide support the hemodynamic of spontaneous breathing patients with cardiogenic shock related to right ventricular myocardial infarction? J. Am. Coll. Cardiol., March 15, 2005; 45(6): 965 - 965. [Full Text] [PDF]

				I. Inglessis and M. J. Semigran Does inhaled nitric oxide support the hemodynamic of spontaneous breathing patients with cardiogenic shock related to right ventricular myocardial infarction? Reply J. Am. Coll. Cardiol., March 15, 2005; 45(6): 965 - 966. [Full Text] [PDF]